Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:1135-1141
Published online before print November 7, 2002, doi: 10.1161/01.RES.0000046236.20251.FA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/1135    most recent
01.RES.0000046236.20251.FAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holzknecht, Z. E.
Right arrow Articles by Platt, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holzknecht, Z. E.
Right arrow Articles by Platt, J. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Related Collections
Right arrow Transplantation
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Other Vascular biology
(Circulation Research. 2002;91:1135.)
© 2002 American Heart Association, Inc.


Molecular Medicine

Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection

Zoie E. Holzknecht, Karisha L. Kuypers, Timothy B. Plummer, Josie Williams, Matilda Bustos, Gregory J. Gores, Gregory J. Brunn, Jeffrey L. Platt

From the Departments of Surgery (Z.E.H., K.L.K., T.B.P., J.W., G.J.B., J.L.P.), Gastroenterology (G.J.G.), Pediatrics (J.L.P.), and Immunology (J.L.P.), Mayo Clinic, Rochester, Minn, and the Division of Hepatology and Gene Therapy (M.B.), Universidad de Navarra, Pamplona, Spain.

Correspondence to Jeffrey L. Platt, MD, Transplantation Biology, Medical Sciences Building, Room 2-66, Mayo Clinic, 200 First St Southwest, Rochester, MN 55905. E-mail platt.jeffrey{at}mayo.edu

Acute vascular or humoral rejection, a vexing outcome of organ transplantation, has been attributed by some to activation and by others to apoptosis of endothelial cells in the graft. We asked which of these processes causes acute vascular rejection by tracing the processes during the development of acute vascular rejection in porcine cardiac xenografts performed in baboons. Apoptosis, assayed by terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling (TUNEL), expression of activated caspase-3, and proapoptotic genes Bax and Bcl-xL, was not detected until acute vascular rejection was well advanced, and even then, apoptosis was largely confined to myocytes. Activation of the endothelium, as evidenced by expansion of rough endoplasmic reticulum and increased ribosomal antigen and phospho-p70 S6 kinase, occurred early in the course of acute vascular rejection and progressed through the disease process. These findings suggest that acute vascular rejection is caused by an active metabolic process and not by apoptosis in the endothelium.


Key Words: apoptosis • endothelial cells • xenotransplantation • cardiac transplantation




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. Shimizu, Y. Hisashi, K. Kuwaki, Y.-L. Tseng, F. J.M.F. Dor, S. L. Houser, S. C. Robson, H.-J. Schuurman, D. K.C. Cooper, D. H. Sachs, et al.
Thrombotic Microangiopathy Associated with Humoral Rejection of Cardiac Xenografts from {alpha}1,3-Galactosyltransferase Gene-Knockout Pigs in Baboons
Am. J. Pathol., June 1, 2008; 172(6): 1471 - 1481.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. T. Jindra, A. Hsueh, L. Hong, D. Gjertson, X.-D. Shen, F. Gao, J. Dang, P. S. Mischel, W. M. Baldwin III, M. C. Fishbein, et al.
Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts
J. Immunol., February 15, 2008; 180(4): 2214 - 2224.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Shimizu, K. Yamada, S. Yamamoto, J. M. Lavelle, R. N. Barth, S. C. Robson, D. H. Sachs, and R. B. Colvin
Thrombotic Microangiopathic Glomerulopathy in Human Decay Accelerating Factor-Transgenic Swine-to-Baboon Kidney Xenografts
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2732 - 2745.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Cascalho, B. M. Ogle, and J. L. Platt
Xenotransplantation and the Future of Renal Replacement
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1106 - 1112.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ghanekar, M. Mendicino, H. Liu, W. He, M. Liu, R. Zhong, M. J. Phillips, G. A. Levy, and D. R. Grant
Endothelial Induction of fgl2 Contributes to Thrombosis during Acute Vascular Xenograft Rejection
J. Immunol., May 1, 2004; 172(9): 5693 - 5701.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. P. Mazer and D. J. Pinsky
Alive and Kicking: Endothelium at the Geographic Nexus of Vascular Rejection
Circ. Res., December 13, 2002; 91(12): 1085 - 1088.
[Full Text] [PDF]